Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06337292 · ClinicalTrials.gov registry record · Phase 3
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
A Phase 3 study of Wound Heal and Fracture of Tibia, sponsored by Major Extremity Trauma Research Consortium.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 352
- Enrollment target
- 2
- Study locations
NCT06337292 is a Phase 3 study of Wound Heal and Fracture of Tibia that is actively recruiting participants, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 352 participants, above the 104-participant average among 23 other Wound Heal trials with a reported enrollment target (238% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06337292, a Phase 3 study of Wound Heal and Fracture of Tibia, is actively recruiting participants, sponsored by Major Extremity Trauma Research Consortium.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 352 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a multi-center, pragmatic, parallel arm randomized controlled trial (RCT) of 352 patients with high-risk open or closed tibial plateau fracture, high-risk open or closed tibial pilon fracture, or open tibial shaft fracture with incision \>3cm. Eligible participants will be randomized to receive either incisional negative pressure wound therapy (NPWT) or a non-suction standard-of-care wound dressing for their definitive wound management. The primary outcome will be a composite outcome to evaluate clinical status 3 months after randomization. The secondary outcomes will independently assess the components of the primary outcome.
Conditions Studied
Interventions
- DEVICE Incisional Negative Pressure Wound Therapy (NPWT)
Study Locations (2)
Maryland
- University of Maryland R Adams Cowley Shock Trauma Center - Baltimore
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06337292
The ClinicalTrials.gov registry entry for NCT06337292 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 104-participant average among 23 other Wound Heal trials with a reported enrollment target (238% higher). The listed sponsor is Major Extremity Trauma Research Consortium, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Wound Heal appearing as the primary indexed condition, and to 1 intervention - of which Incisional Negative Pressure Wound Therapy (NPWT) is the first listed.
NCT06337292 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06337292 about?
NCT06337292 is a clinical study titled "Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures". This is a multi-center, pragmatic, parallel arm randomized controlled trial (RCT) of 352 patients with high-risk open or closed tibial plateau fracture, high-risk open or closed tibial pilon fracture, or open tibial shaft fracture with incision \>3cm. Eligible participants will be randomized to rece...
What is the current status of trial NCT06337292?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 352 participants. The study started on 2025-01-01. Estimated completion is 2028-12-31.
What conditions does trial NCT06337292 study?
This clinical trial studies the following conditions: Wound Heal, Fracture of Tibia, Infected Wound, Wound Complication, Wound Dehiscence.
What interventions are being tested in trial NCT06337292?
The interventions under investigation include: Incisional Negative Pressure Wound Therapy (NPWT) (DEVICE).
Who is sponsoring clinical trial NCT06337292?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06337292 being conducted?
This trial has 2 study locations across Maryland, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Heal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
RECRUITING · Phase 3
-
Tissue Repair Gel in Venous Leg Ulcers (US)
RECRUITING · Phase 3
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Dermabrasion in Mohs: Split-Scar Trial
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.